Dr. Corrine Zarwan, MD
Claim this profileLahey Hospital and Medical Center
Studies Breast Cancer
Studies Breast cancer
16 reported clinical trials
47 drugs studied
Area of expertise
1Breast Cancer
ER positive
Stage IV
HER2 positive
2Breast Cancer
ER positive
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Corrine Zarwan, MD is currently running
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
More about Corrine Zarwan, MD
Clinical Trial Related8 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Corrine Zarwan, MD has experience with
- Paclitaxel
- Atezolizumab
- Trastuzumab
- Pertuzumab
- Capivasertib
- Durvalumab
Breakdown of trials Corrine Zarwan, MD has run
Breast Cancer
Breast cancer
Ovarian Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Corrine Zarwan, MD specialize in?
Corrine Zarwan, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are Stage IV.
Is Corrine Zarwan, MD currently recruiting for clinical trials?
Yes, Corrine Zarwan, MD is currently recruiting for 2 clinical trials in Burlington Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Corrine Zarwan, MD has studied deeply?
Yes, Corrine Zarwan, MD has studied treatments such as Paclitaxel, Atezolizumab, Trastuzumab.
What is the best way to schedule an appointment with Corrine Zarwan, MD?
Apply for one of the trials that Corrine Zarwan, MD is conducting.
What is the office address of Corrine Zarwan, MD?
The office of Corrine Zarwan, MD is located at: Lahey Hospital and Medical Center, Burlington, Massachusetts 01805 United States. This is the address for their practice at the Lahey Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.